This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Article 1 of the Pharmaceutical Law of 19/12/2014, Journal of Laws of the Republic of Poland 2015, 0, item 28, as amended.Article 1 of the Pharmaceutical Law of 19/12/201420150, item 28, as amendedSearch in Google Scholar
Article 118 of the Pharmaceutical Law of 06/09/2001, Journal of Laws of the Republic of Poland 2001, 126, item 1381, as amended.Article 118 of the Pharmaceutical Law of 06/09/20012001126, item 1381, as amendedSearch in Google Scholar
Article 2 point 9 of the Pharmaceutical Law of 06/09/2001, Journal of Laws of the Republic of Poland 2001, 126, item 1381, as amended.Article 2 point 9 of the Pharmaceutical Law of 06/09/20012001126, item 1381, as amendedSearch in Google Scholar
Article 81 of Directive 2001/82/EC, as amended by Directive 2004/28/EC, of the European Parliament and the Council.Article 81 of Directive2001/82/ECSearch in Google Scholar
Article 82 of Directive 2001/82/EC, as amended by Directive 2004/28/EC, of the European Parliament and the Council.Article 82 of Directive2001/82/ECSearch in Google Scholar
Chang Y., Brewer N.T., Rinas A.C., Schmitt K., Smith J.S.: Evaluating the impact of human papillomavirus vaccines. Vaccine 2009, 27, 4355–4362. doi:10.1016/j.vaccine.2009.03 .008. PMID 19515467.ChangY.BrewerN.T.RinasA.C.SchmittK.SmithJ.S.Evaluating the impact of human papillomavirus vaccines20092743554362doi10.1016/j.vaccine.2009.03.008PMID 1951546719515467Open DOISearch in Google Scholar
Council of Europe: Presentation of the EDQM and its activities. 2016. https://www.youtube.com/watch?v=YWN7BsUyipc2016https://www.youtube.com/watch?v=YWN7BsUyipcSearch in Google Scholar
Encyclopedia Britannica: Entry on vaccines. https://www.britannica.com/science/vaccinehttps://www.britannica.com/science/vaccineSearch in Google Scholar
EudraVigilance – European database of reports on suspected adverse drug reactions: Medicines in the EU. http://www.adrreports.eu/en/medicines_in_EU.htmlhttp://www.adrreports.eu/en/medicines_in_EU.htmlSearch in Google Scholar
European Directorate for the Quality of Medicines & HealthCare (EDQM): Institutional Brochure. https://www.edqm.eu/sites/default/files/institutional-brochure-edqm.pdfhttps://www.edqm.eu/sites/default/files/institutional-brochure-edqm.pdfSearch in Google Scholar
European Directorate for the Quality of Medicines & HealthCare (EDQM): Levels of collaboration within the General European OMCL Network (GEON). https://www.edqm.eu/en/Levels-of-Collaboration-within-the-OMCL-129.htmlhttps://www.edqm.eu/en/Levels-of-Collaboration-within-the-OMCL-129.htmlSearch in Google Scholar
European Directorate for the Quality of Medicines & HealthCare (EDQM): Official website. https://www.edqm.eu/https://www.edqm.eu/Search in Google Scholar
European Medicines Agency: Official website. https://www.ema.europa.eu/https://www.ema.europa.eu/Search in Google Scholar
European Union: Website listing EU agencies. https://europa.eu/european-union/about-eu/agencies/ema_plhttps://europa.eu/european-union/about-eu/agencies/ema_plSearch in Google Scholar
Fijałek Z.: Role of the National Medicines Institute in quality assurances and safety of medicinal products and medical devices. Przegl Med Uniw Rzeszowskiego i Narod Inst Lek w Warszawie 2010, 3, 259–270.FijałekZ.Role of the National Medicines Institute in quality assurances and safety of medicinal products and medical devices20103259270Search in Google Scholar
Fiore A.E., Bridges C.B., Cox N.J.: Seasonal influenza vaccines. Current Topics Microbiol Immunol 2009, 333, 43–82. doi:10.1007/978-3-540-92165-3_3. ISBN 978-3-540-92164-6. PMID 19768400.FioreA.E.BridgesC.B.CoxN.J.Seasonal influenza vaccines20093334382doi10.1007/978-3-540-92165-3_3ISBN 978-3-540-92164-6. PMID 1976840019768400Open DOISearch in Google Scholar
Guo Y., Lei K., Tang L.: Neoantigen vaccine delivery for personalized anticancer immunotherapy. Front Immunol 2018, 9, 1–8. doi: 10.3389/fimmu.2018.01499. eCollection 2018.GuoY.LeiK.TangL.Neoantigen vaccine delivery for personalized anticancer immunotherapy2018918doi10.3389/fimmu.2018.01499eCollection 2018603611430013560Open DOISearch in Google Scholar
Kretzschmar E., Muckenfuss H., Pfleiderer M.: Official batch control of influenza vaccines: Is it still useful? Vaccine 2018, 36, 2364–2370.KretzschmarE.MuckenfussH.PfleidererM.Official batch control of influenza vaccines: Is it still useful?2018362364237010.1016/j.vaccine.2018.02.07829580639Search in Google Scholar
Liesegang T.J.: Varicella zoster virus vaccines: effective, but concerns linger. Canadian J Ophthalmol 2009, 44, 379–384. doi:10.3129/i09-126. PMID 19606157.LiesegangT.J.Varicella zoster virus vaccines: effective, but concerns linger200944379384doi10.3129/i09-126PMID 1960615719606157Open DOISearch in Google Scholar
Markey K., Douglas-Bardsley A., Hockley J., Le Tallec D., Costanzo A.: Calibration of pertussis toxin BRP batch 1 in a standardised CHO cell-based clustering assay. Pharmeur Bio Sci Notes 2018, 112–123.MarkeyK.Douglas-BardsleyA.HockleyJ.Le TallecD.CostanzoA.Calibration of pertussis toxin BRP batch 1 in a standardised CHO cell-based clustering assay2018112123Search in Google Scholar
Matejtschuk P., Duru C., Bristow A.F., Burns C.J., Cowper B., Daas A., Costanzo A.: Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISA. Pharmeur Bio Sci Notes 2019, 11–26.MatejtschukP.DuruC.BristowA.F.BurnsC.J.CowperB.DaasA.CostanzoA.Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISA20191126Search in Google Scholar
Medycyna Praktyczna: Klasyfikacja i skład szczepionek (Classification and composition of vaccines (in Polish)). https://www.mp.pl/pacjent/choroby-zakazne/szczepienia/158371,klasyfikacja-i-sklad-szczepionekhttps://www.mp.pl/pacjent/choroby-zakazne/szczepienia/158371,klasyfikacja-i-sklad-szczepionekSearch in Google Scholar
Morgeaux S., Koy A., Manniam I., Regourd E., Variot P., Milne C.: Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISA. Pharmeur Bio Sci Notes 2019, 1–10.MorgeauxS.KoyA.ManniamI.RegourdE.VariotP.MilneC.Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISA2019110Search in Google Scholar
Sass J., Becker K., Ludmann D., Pantazoglou E., Dewenter H., Thun S.: Intercoder reliability of mapping between pharmaceutical dose forms in the German Medication Plan and EDQM Standard Terms. Stud Health Technol Inform 2018, 247, 845–849.SassJ.BeckerK.LudmannD.PantazoglouE.DewenterH.ThunS.Intercoder reliability of mapping between pharmaceutical dose forms in the German Medication Plan and EDQM Standard Terms2018247845849Search in Google Scholar
United States Centers for Disease Control and Prevention: A CDC framework for preventing infectious diseases: Sustaining the Essentials and Innovating for the Future. https://www.cdc.gov/ddid/framework.htmlhttps://www.cdc.gov/ddid/framework.htmlSearch in Google Scholar
United States Department of Health and Human Services: Types of vaccines. https://www.vaccines.gov/basics/types/index.htmlhttps://www.vaccines.gov/basics/types/index.htmlSearch in Google Scholar
Wanko R., Unkelbach U.: European network of official medicines control laboratories: international OMCL Working Group combating counterfeit and other illegal medicines. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2017, 60, 1221–1227. doi: 10.1007/s00103-017-2625-7.WankoR.UnkelbachU.European network of official medicines control laboratories: international OMCL Working Group combating counterfeit and other illegal medicines20176012211227doi10.1007/s00103-017-2625-728921172Open DOISearch in Google Scholar